DPharm Idol Disrupt – The Nurocor Clinical Platform:
Driving Meaningful Change Through Innovation
The DPharm Advisory Board selected Nurocor as one of the finalists to present as part of DPharm 2023 Idol Disrupt in Boston. Maria Perkinson (Nurocor SVP, Process and Technology Optimization) presented on How Nurocor Drives Innovation in Clinical Trials to help patients through a scalable and sustainable future for clinical development.
View Maria’s video by clicking on the yourtube link to the right.